Contributions to collective works (2)
  1. 1. De Vriese, C., Perret, J., & Delporte, C. (2014). Current and future clinical applications of ghrelin. In Endocrine Diseases (pp. 65-102). IConcept Press Ltd.
  2. 2. De Vriese, C., Perret, J., & Delporte, C. (2009). Ghrelin: a peptide involved in the control of appetite. In Appetite and nutritional assessment (pp. 1-48). New York, USA: Ellsworth S.J. and Schuster R.C.(Nova Science Publishers Inc.).
    3.   Peer-reviewed journal articles (41)
  3. 1. Danneel, C., Sauvage, C., Hayef, M. N., Desmet, V., Surquin, M., Nortier, J., & De Vriese, C. (2025). Critical Review of the Benefit from Early Pharmacological and Dietary Support for Patients with Moderate-to-Severe (Non-Terminal) Chronic Kidney Disease. Biomedicines, 13(4). doi:10.3390/biomedicines13040994
  4. 2. Biset, N., Rosiere, A., Lartigue, V., Pochet, S., & De Vriese, C. (2024). Patients and healthcare practitioners' perspective on the development of a digital interprofessional intervention for COPD. Digital health, 10, 20552076241288317. doi:10.1177/20552076241288317
  5. 3. Schils, A., Lechon, A.-S., Rondeaux, S., Souard, F., Van Laethem, J.-L., Pochet, S., Mathieu, V., & De Vriese, C. (2023). Cancer patients' behaviors and attitudes toward natural health products. BMC complementary medicine and therapies, 23(1), 442, 1-14. doi:10.1186/s12906-023-04278-0
  6. 4. Macé, F., De Vriese, C., Nelissen-Vrancken, M., Ruggli, M., Brülhart, M., & Peyron, C. (2023). General practitioners-community pharmacists pharmacotherapy discussion groups: Analysis of their implementation through a series of case studies. Exploratory research in clinical and social pharmacy, 12, 100331. doi:10.1016/j.rcsop.2023.100331
  7. 5. Biset, N., Lelubre, M., Pochet, S., & De Vriese, C. (2023). Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium. Pharmaceuticals, 16(7). doi:10.3390/ph16071030
  8. 6. Rondeaux, S., Braeckman, T., Beckwé, M., El Oueriaghli El Ghammaz, D., Devroey, D., & De Vriese, C. (2023). Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy. International journal of environmental research and public Health, 20(4). doi:10.3390/ijerph20042819
  9. 7. Pochet, S., Lechon, A.-S., Lescrainier, C., De Vriese, C., Mathieu, V., Hamdani, J., & Souard, F. (2022). Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database. Scientific reports, 12(1), 14178. doi:10.1038/s41598-022-17704-z
  10. 8. Rondeaux, S., Braeckman, T., Beckwé, M., Biset, N., Maesschalck, J., Duquet, N., De Wulf, I., Devroey, D., & De Vriese, C. (2022). Diabetes and Cardiovascular Diseases Risk Assessment in Community Pharmacies: An Implementation Study. International journal of environmental research and public Health, 19(14). doi:10.3390/ijerph19148699
  11. 9. Biset, N., Kestens, W., Detemmerman, D., Lona, M., Karakaya, G., Ceuppens, A., Pochet, S., & De Vriese, C. (2022). Analysis of the Consumption of Drugs Prescribed for the Treatment of Asthma in Belgian Children. International Journal of Environmental Research and Public Health, 19(1), 548. doi:10.3390/ijerph19010548
  12. 10. Koubaity, M., Lechon, A.-S., Amighi, K., Van Nuffelen, M., Moreau, M., Meert, A.-P., & De Vriese, C. (2021). Drug-related problems and risk factors related to unplanned hospital readmission among cancer patients in Belgium. Supportive care in cancer. doi:10.1007/s00520-020-05916-w
    13. << Previous 1 2 3 4 5 6 7 8 9 Next >>